Tetradecylthioacetic Acid Increases Fat Metabolism and Improves Cardiac Function in Experimental Heart Failure

[1]  A. Viste,et al.  Long-term treatment with the pan-PPAR agonist tetradecylthioacetic acid or fish oil is associated with increased cardiac content of n-3 fatty acids in rat , 2012, Lipids in Health and Disease.

[2]  L. Tavazzi,et al.  Effects of n‐3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI‐HF trial , 2010, European journal of heart failure.

[3]  M. Silletta,et al.  Omega-3 fatty acids and heart failure , 2009, Current atherosclerosis reports.

[4]  R. Tian,et al.  Metabolic therapy at the crossroad: how to optimize myocardial substrate utilization? , 2009, Trends in cardiovascular medicine.

[5]  K. Clarke,et al.  Cardiac peroxisome proliferator-activated receptor-alpha activation causes increased fatty acid oxidation, reducing efficiency and post-ischaemic functional loss. , 2009, Cardiovascular research.

[6]  M. Bilsen,et al.  Metabolic remodelling of the failing heart: beneficial or detrimental? , 2008 .

[7]  Gissi-Hf Investigators.  Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial , 2008, The Lancet.

[8]  L. Tavazzi,et al.  ect of n-3 polyunsaturated fatty acids in patients with chronic heart failure ( the GISSI-HF trial ) : a randomised , double-blind , placebo-controlled trial , 1980 .

[9]  A. Pession,et al.  N − 3 PUFAs modulate global gene expression profile in cultured rat cardiomyocytes. Implications in cardiac hypertrophy and heart failure , 2007, FEBS letters.

[10]  T. Roche,et al.  Pyruvate dehydrogenase kinase regulatory mechanisms and inhibition in treating diabetes, heart ischemia, and cancer , 2007, Cellular and Molecular Life Sciences.

[11]  A. Bonen,et al.  Long-chain fatty acid uptake and FAT/CD36 translocation in heart and skeletal muscle. , 2005, Biochimica et biophysica acta.

[12]  J. Falck,et al.  Cytochrome P450 and arachidonic acid metabolites: role in myocardial ischemia/reperfusion injury revisited. , 2005, Cardiovascular research.

[13]  William C Stanley,et al.  Myocardial substrate metabolism in the normal and failing heart. , 2005, Physiological reviews.

[14]  K. Tronstad,et al.  The metabolic syndrome and the hepatic fatty acid drainage hypothesis. , 2005, Biochimie.

[15]  K. Witte,et al.  Fish oils – adjuvant therapy in chronic heart failure? , 2004, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[16]  R. Berge,et al.  Fish protein hydrolysate reduces plasma total cholesterol, increases the proportion of HDL cholesterol, and lowers acyl-CoA:cholesterol acyltransferase activity in liver of Zucker rats. , 2004, The Journal of nutrition.

[17]  S. Silver,et al.  Heart Failure , 1937, The New England journal of medicine.

[18]  K. Tronstad,et al.  Metabolic effects of thia fatty acids , 2002, Current opinion in lipidology.

[19]  J. Nordrehaug,et al.  Sustained retention of tetradecylthioacetic acid after local delivery reduces angioplasty-induced coronary stenosis in the minipig. , 2001, Cardiovascular research.

[20]  K. Kristiansen,et al.  Tetradecylthioacetic acid inhibits growth of rat glioma cells ex vivo and in vivo via PPAR-dependent and PPAR-independent pathways. , 2001, Carcinogenesis.

[21]  B. Swynghedauw,et al.  Molecular mechanisms of myocardial remodeling. , 1999, Physiological reviews.

[22]  O. Smiseth,et al.  Transient, isopeptide-specific induction of myocardial endothelin-1 mRNA in congestive heart failure in rats. , 1997, American journal of physiology. Heart and circulatory physiology.

[23]  R. Berge,et al.  Alkylthioacetic acids (3-thia fatty acids) as non-beta-oxidizable fatty acid analogues: a new group of hypolipidemic drugs. III. Dissociation of cholesterol- and triglyceride-lowering effects and the induction of peroxisomal beta-oxidation. , 1989, Journal of lipid research.

[24]  M. Connock,et al.  A sensitive spectrophotometric assay for peroxisomal acyl-CoA oxidase. , 1985, The Biochemical journal.

[25]  J. Bremer,et al.  The effect of fasting on the activity of liver carnitine palmitoyltransferase and its inhibition by malonyl-CoA. , 1981, Biochimica et biophysica acta.